HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Recombinant Swinepox Virus for Veterinary Vaccine Development.

Abstract
Poxvirus-vectors have been widely used in vaccine development for several important human and animal diseases; some of these vaccines have been licensed and used extensively. Swinepox virus (SPV) is well suited to develop recombinant vaccines because of its large packaging capacity for recombinant DNA, its host range specificity, and its ability to induce appropriate immune responses.
AuthorsHong-Jie Fan, Hui-Xing Lin
JournalMethods in molecular biology (Clifton, N.J.) (Methods Mol Biol) Vol. 1349 Pg. 163-75 ( 2016) ISSN: 1940-6029 [Electronic] United States
PMID26458836 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: